🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: to evaluate the efficacy and safety of the Recombinant Non-immun...
Status
Completed
Location
V.F. Dolgopolov Vyselki Central District Hospital
Start Date
2020-12-15
Trial ID
NCT04688320
Treatments Being Tested
The aim of the study is to determine if single-bolus recombinant nonimmunog...
Status
Completed
Location
Regional Clinical Hospital
Start Date
2017-03-18
Trial ID
NCT03151993
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Status
Recruiting
Location
Puyang Oilfield General Hospital
Start Date
2025-11-30
Trial ID
NCT07201688
To explore the safe and efficacious dose of rhTNK-tPA injection administere...
Status
Completed
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2018-05-12
Trial ID
NCT04676659
Treatments Being Tested
The EARLY-MYO (EARLY routine catheterization after alteplase fibrinolysis v...
Status
Completed
Location
RenJi Hospital
Start Date
2014-01-13
Trial ID
NCT01930682
Treatments Being Tested
The study is a prospective, multicenter, randomized, double-blind, placebo-...
Status
Unknown
Location
23rd Floor, City Square, No.160 Qiaokou Road, Qiaokou District
Start Date
2021-12-09
Trial ID
NCT05188417
Treatments Being Tested
The objective of the study is to determine the safety and efficacy of TNK i...
Status
Terminated
Location
Kaiser Foundation Hospital
Start Date
2008-01
Trial ID
NCT01580618
Treatments Being Tested
The aim of the THEIA study is to determine if Alteplase administrated withi...
Status
Completed
Location
CH Annecy Genevois
Start Date
2018-06-08
Trial ID
NCT03197194
Treatments Being Tested
The primary purpose of this Phase 2 study is to optimize Plasmin delivery b...
Status
Completed
Location
Kaleida Health System
Start Date
2010-12
Trial ID
NCT01222117
Treatments Being Tested